BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20408991)

  • 1. Administration of zonisamide in three cases of dementia with Lewy bodies.
    Odawara T; Shiozaki K; Togo T; Hirayasu Y
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):327-9. PubMed ID: 20408991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Edwards K; Royall D; Hershey L; Lichter D; Hake A; Farlow M; Pasquier F; Johnson S
    Dement Geriatr Cogn Disord; 2007; 23(6):401-5. PubMed ID: 17409748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
    Liepelt I; Maetzler W; Blaicher HP; Gasser T; Berg D
    Dement Geriatr Cogn Disord; 2007; 23(6):351-67. PubMed ID: 17389795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
    Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
    Gallini A; Sommet A; Salandini AM; Veyssière P; Montastruc JL; Montastruc JL
    Mov Disord; 2007 Oct; 22(13):1980-1. PubMed ID: 17657810
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment.
    Borroni B; Agosti C; Padovani A
    Arch Gerontol Geriatr; 2008; 46(1):101-6. PubMed ID: 17467082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study.
    Murata M; Odawara T; Hasegawa K; Iiyama S; Nakamura M; Tagawa M; Kosaka K
    Neurology; 2018 Feb; 90(8):e664-e672. PubMed ID: 29367449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zonisamide has beneficial effects on Parkinson's disease patients.
    Murata M; Horiuchi E; Kanazawa I
    Neurosci Res; 2001 Dec; 41(4):397-9. PubMed ID: 11755227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-Label Extension of a Phase three Randomized Controlled Trial.
    Odawara T; Hasegawa K; Kajiwara R; Takeuchi H; Tagawa M; Kosaka K; Murata M
    Am J Geriatr Psychiatry; 2022 Mar; 30(3):314-328. PubMed ID: 34420834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies.
    Firbank MJ; Burn DJ; McKeith IG; O'Brien JT
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):776-82. PubMed ID: 16035122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
    Mori S; Mori E; Iseki E; Kosaka K
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Management of Dementia with Lewy Bodies.
    Hershey LA; Coleman-Jackson R
    Drugs Aging; 2019 Apr; 36(4):309-319. PubMed ID: 30680679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials.
    Hasegawa K; Kochi K; Maruyama H; Konishi O; Toya S; Odawara T
    J Alzheimers Dis; 2021; 79(2):627-637. PubMed ID: 33337365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine.
    Ridha BH; Josephs KA; Rossor MN
    Neurology; 2005 Aug; 65(3):481-2. PubMed ID: 16087923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of extrapyramidal and psychotic symptoms with zonisamide in a patient with dementia with Lewy bodies.
    Sato S; Mizukami K; Asada T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1130-1. PubMed ID: 20420876
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological management of psychosis in elderly patients with parkinsonism.
    Hasnain M; Vieweg WV; Baron MS; Beatty-Brooks M; Fernandez A; Pandurangi AK
    Am J Med; 2009 Jul; 122(7):614-22. PubMed ID: 19559160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy.
    Takahashi S; Mizukami K; Yasuno F; Asada T
    Psychogeriatrics; 2009 Jun; 9(2):56-61. PubMed ID: 19604326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.